Celgene (NASDAQ:CELG)

buy sell stocks

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

Monday brought a much needed sell-off after two and half weeks of almost constant rallying, but the sell-off was minimal. Tuesday's opening indication on the S&P 500 and Dow is ...
Read Full Story »
biotech word cloud

Short Sellers Grow More Aggressive on Major Biotechs

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
biotech word cloud

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
biotech word cloud

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, October 14. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
biotech word cloud

Top Health Care Earnings Coming Next Week

Earnings season is now in full swing, and we have put together a preview of some of the world’s largest players in the health care sector. This current quarter ahead ...
Read Full Story »
graph

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

It’s a tired refrain, as we have written about it for over a year, but the beating that the health care sector has taken, especially the biotechs, may be providing ...
Read Full Story »
Money and plant

Top Biotech Plays Highlight Jefferies Growth Stocks to Buy

More and more, the companies that we cover on Wall Street are starting to agree that while the future's still bright for the U.S. economy, it may be one of growth ...
Read Full Story »
biotech word cloud

Short Sellers Have Mixed Views on Major Biotechs

The short interest data are out for the most recent settlement date, September 30. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
Pills and tablets

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

For the last year, many of the top pharmaceutical and biotech stocks have been under pressure from comments made by politicians looking to whip up voter enthusiasm. Recent issues over ...
Read Full Story »
biotech word cloud

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the most recent settlement date, September 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
Test tubes

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

We have talked in detail about how the political rhetoric has weighed upon the biotech industry. Toss in some scrutiny of pricing over a widely used product, and you have ...
Read Full Story »
blood cells

Agios Files for Secondary Offering

Agios Pharmaceuticals Inc. (NASDAQ: AGIO) has filed with the U.S. Securities and Exchange Commission (SEC) regarding its secondary offering. The company intends to offer up to $150 million of its ...
Read Full Story »
biotech word cloud

Short Sellers Run for Cover From Major Biotechs

Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside. In fact, a cure or incredible new breakthrough in cancer ...
Read Full Story »
clinical trials

4 Key BioPharma Movers in the Past Week

A few biotech companies made impressive runs over the course of this past week. In the past 52 weeks, biotech and pharmaceutical stocks have been absolutely crushed. However the year ...
Read Full Story »
Female patient on gurney

Did Agios Just Speed Up Its Business Plan by 2 Years?

Celgene Corp. (NASDAQ: CELG) is making a move out of left field that has sent shares of its partner Agios Pharmaceuticals Inc. (NASDAQ: AGIO) significantly higher. In a surprise move, Celgene is ...
Read Full Story »